Pharmaceuticals

Central Carbon Metabolite Based Polymers for Tissue Regeneration

Rescue from Glycolysis and mRNA Based Vaccines

Central Carbon Metabolite Based Polymers for Immunotherapy

Metabolite Delivery for Modulating Metabolic Pathways of Cells

Neutrophil based CAR Therapies for Treatment

Metabolic Reprogramming of Immune for Autoimmune Disorders Prevention/Reversal

Method for Repurposing FDA-approved Therapeutics & Composition for Treating Mesothelioma

Metabolically-fit Immunotherapies Portfolio

Cyclodepsipeptide compounds presenting anti-cancer and anti-infective activity, and their synthesis

Creation of Multivalent Aptamers to Target Effector T Cells to Attack Tumor Cells